+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Respiratory Drugs Market Research Reports

Investigation Report on China's Omalizumab Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Omalizumab Market 2021-2025

  • Report
  • June 2021
  • 50 Pages
  • China
From
Investigation Report on China's Tiotropium Bromide Market 2021-2025 - Product Thumbnail Image

Investigation Report on China's Tiotropium Bromide Market 2021-2025

  • Report
  • May 2021
  • 50 Pages
  • China
From
Investigation Report on China's Ambroxol Market, 2021-2025 - Product Thumbnail Image

Investigation Report on China's Ambroxol Market, 2021-2025

  • Report
  • April 2021
  • China
From
Investigation Report on China's Loratadine Market, 2018-2022 - Product Thumbnail Image

Investigation Report on China's Loratadine Market, 2018-2022

  • Report
  • December 2018
  • 30 Pages
  • China
From
Spiriva - Product Thumbnail Image

Spiriva

  • Report
  • July 2018
  • 33 Pages
  • Global
From
Nucala - Product Thumbnail Image

Nucala

  • Report
  • July 2018
  • 27 Pages
  • Global
From
Drug Analysis: Cinqair - Product Thumbnail Image

Drug Analysis: Cinqair

  • Drug Pipelines
  • February 2018
  • 16 Pages
  • Global
From
Asthma Forecast and Market Analysis to 2024 - Product Thumbnail Image

Asthma Forecast and Market Analysis to 2024

  • Report
  • February 2018
  • 680 Pages
  • Global
From
Ofev - API Insight, 2022 - Product Thumbnail Image

Ofev - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Pertussis (Whooping Cough) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 106 Pages
  • Global
From
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 43 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 307 Pages
  • Global
From
Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Tuberculosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 359 Pages
  • Global
From
Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bronchiectasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 112 Pages
  • Global
From
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 121 Pages
  • Middle East
From
Sulfamethoxazole Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Sulfamethoxazole Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Product Type

  • Report
  • November 2025
  • 73 Pages
  • Global
From
Primary Ciliary Dyskinesia Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Primary Ciliary Dyskinesia Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2024
  • 82 Pages
  • Global
From
Alpha-Antitrypsin Deficiency Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Alpha-Antitrypsin Deficiency Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2024
  • 94 Pages
  • Global
From
Epinastine HCL Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Epinastine HCL Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • February 2024
  • 92 Pages
  • Global
From
Fexofenadine Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type - Product Thumbnail Image

Fexofenadine Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • Report
  • February 2024
  • 85 Pages
  • Global
From
Loading Indicator

The Respiratory Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat respiratory diseases. These drugs are used to treat a variety of conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Commonly prescribed respiratory drugs include bronchodilators, corticosteroids, and antibiotics. The Respiratory Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Companies in the market include GlaxoSmithKline, AstraZeneca, Merck & Co., Novartis, and Boehringer Ingelheim. These companies are constantly researching and developing new drugs to treat respiratory diseases, as well as improving existing treatments. Show Less Read more